Exchange: NSE·Updated 04:00 PM GMT+5:30

PPLPHARMA.NSE News

News
all
press releases
Indian Markets Extend Gains For Second Week; Nifty Ends Near 25,300, Sensex Surges Over 1,000 Points
Optimism over an India–US trade deal and easing geopolitical tensions boosted investor sentiment. Buying in real estate, pharma, and PSU banks offset weakness in metals and tech stocks.
Stocktwits
More News
US Biosecure Act Boosts Indian Pharma: CDMO Stocks Gained Upto 5%
The legislation seeks to protect American biotech and health data from potential foreign threats, especially from Chinese firms
Stocktwits
India’s Healthcare Index Sinks After Trump’s Pharma Tariff Blow — SEBI Analyst Sees Risks For Gland, Biocon, Dr. Reddy’s
The analyst noted that Syngene, Piramal Pharma, and Zydus Lifesciences may be better positioned, as their contract manufacturing models and biologics portfolios are less susceptible to the tariff impact.
Stocktwits
Piramal Pharma, KEI, HCC, Geojit Financial Among Top Picks On SEBI Analysts’ Radar
Analysts see Polycab and Park Hotels showing promising momentum.
Stocktwits
Bullish Signals For Piramal Pharma: SEBI Analyst Flags Technical Breakout, Sees Over 10% Upside By October
Technical charts and retail sentiment now indicate bullish momentum.
Stocktwits
Midcap Breakouts: SEBI RA Flags HEG, DMCC, PPL Pharma, Precision Wires For Upside Moves:
The analyst has highlighted four midcap names showing bullish patterns with strong volume and RSI support.
Stocktwits

Advertisement|Remove ads.